RETINOVITREOUS ASSOCIATES LTD
NPI: 1659326452
· PLYMOUTH MEETING, PA 19462
· 207WX0107X
$5.10M
Total Medicaid Paid
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
|---|
| 2018 |
4,110 |
$30K |
| 2019 |
294 |
$10K |
| 2020 |
3,592 |
$366K |
| 2021 |
23,443 |
$1.92M |
| 2022 |
26,350 |
$839K |
| 2023 |
29,742 |
$994K |
| 2024 |
24,614 |
$938K |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
|
29,385 |
24,404 |
$2.36M |
| 92134 |
|
49,881 |
46,106 |
$969K |
| J0178 |
Aflibercept injection |
8,646 |
8,037 |
$935K |
| J2778 |
Ranibizumab injection |
4,072 |
3,746 |
$456K |
| J9035 |
Bevacizumab injection |
6,237 |
6,032 |
$131K |
| 92250 |
|
2,369 |
2,265 |
$100K |
| 92012 |
|
9,006 |
8,387 |
$68K |
| 99204 |
|
414 |
406 |
$22K |
| Q5128 |
Inj, cimerli, 0.1 mg |
71 |
68 |
$19K |
| 92014 |
|
683 |
658 |
$13K |
| 99214 |
|
423 |
414 |
$12K |
| 67228 |
|
15 |
14 |
$6K |
| 92201 |
|
137 |
133 |
$2K |
| 76512 |
|
17 |
13 |
$834.13 |
| 92235 |
|
24 |
24 |
$676.36 |
| 99213 |
|
24 |
24 |
$447.25 |
| J7999 |
Compounded drug, noc |
152 |
127 |
$0.00 |
| C9257 |
Bevacizumab injection |
576 |
553 |
$0.00 |
| J2777 |
Inj, faricimab-svoa, 0.1mg |
13 |
13 |
$0.00 |